View Clinical Trial (Medical Research Study)
A Mindfulness-based Intervention for Treatment of Anxiety in ICD (Implantable Cardioverter Defibrillator) Patients - NCT01035294-01655(Clinical Trial 447812)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Worcester |
|
State:
|
|
MA |
| Zip Code: |
|
01655 |
| Conditions: |
|
Anxiety in ICD Patients |
| Purpose: |
|
The purpose of this study is to evaluate the feasibility and preliminary efficacy of a
mindfulness-based behavioral intervention combining breathing and other relaxation exercises
on symptoms of anxiety in patients undergoing the implantation of an implantable
cardioverter defibrillator. This study will pilot test the feasibility and preliminary
efficacy of a mindfulness-based intervention intended to improve mindfulness and anxiety
levels in ICD (Implantable Cardioverter Defibrillators) patients. A randomized controlled
study design will be used, in which an 8 session phone-delivered mindfulness intervention
will be compared to a usual care condition among consecutive candidates for ICD procedures.
The study will be conducted at the Electrophysiology (EPS) Unit at the UMass Memorial
Medical Center. Assessments will be performed at baseline and at the end of the
intervention (9 weeks after enrollment).
|
| Study summary: |
|
The Specific Aims of this pilot study are:
Primary aim:
To determine the feasibility of a randomized clinical trial of a phone-administered,
mindfulness-based training program, as measured by recruitment and retention rates,
treatment adherence and fidelity.
Secondary aims:
1. To obtain preliminary estimates of the effect of a phone delivered mindfulness-based
intervention on mindfulness levels, measured as the difference between baseline and
post-intervention Five Factors of Mindfulness scores (FFM) in the intervention and in
the control group at the end of the intervention. Hypothesis: Mindfulness levels will
improve in the intervention group compared to the control group.
2. To obtain preliminary estimates of the effect of a phone delivered, mindfulness-based
intervention on anxiety, measured as the difference between baseline and
post-intervention Hospital Anxiety and Depression (HAD) anxiety scores in the
intervention and in the control group at the end of the intervention. Hypothesis:
Anxiety levels will be reduced in the intervention group, compared to the control
group.
3. To collect preliminary data about the number of arrhythmic episodes/administered shocks
during the intervention period. Hypothesis: the proportion of patients experiencing
arrhythmic events/shocks will decrease in the intervention vs. the control group. |
| Criteria: |
|
Inclusion Criteria:
1. Age ≥ 21
2. ICD procedure
3. Ability to understand and speak English
4. Access to a telephone
Exclusion Criteria:
1. Inability or unwillingness to give informed consent
2. Signs of cognitive impairment (Blessed Orientation-Memory-Concentration (BOMS)scores
>10)
3. New York Heart Association (NYHA) functional class>III, angina Canadian
Cardiovascular Society(CCS) III and IV or clinically unstable
4. Awaiting coronary by-pass or heart transplantation
5. Co-morbid life threatening condition
6. Ongoing severe depression or psychosis |
|
|
|
| Study is available at: |
|
UMass Memorial Medical Center Worcester, MA 01655 United States
Primary Contact: Elena Salmoirago-Blotcher, MD Email: Elena.Salmoirago-Blotcher@umassmed.edu Phone: 508-856-4413 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|